United Therapeutics reported 20.42 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Amarin 91.05 88.3 Jun/2023
Baxter International 151.95 65.95 Jun/2026
Bayer 3.4 8.75 Mar/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
Biogen 23.23 9.53 Jun/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Emergent BioSolutions 14.4 2.25 Sep/2022
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Halozyme Therapeutics 11.35 11.8 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 29.43 4.9 Jun/2026
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Moderna 27.22 14.51 Jun/2023
Pfizer 11.48 2.16 Jun/2026
PTC Therapeutics 8.76 1.22 Mar/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Sarepta Therapeutics 27.27 0 Mar/2026
Teva Pharmaceutical Industries 24.6 14.53 Jun/2026
United Therapeutics 20.42 3.1 Mar/2026
Vertex Pharmaceuticals 28.05 2.22 Jun/2026